Category - OVARY
ESMO Recommendations On Predictive Biomarker Testing For Homologous Recombination Deficiency And PARP Inhibitor Benefit In Ovarian Cancer
Newly Diagnosed And Relapsed Epithelial Ovarian Cancer: ESMO Clinical Practice Guideline For Diagnosis, Treatment and Follow-up
Chicago Guidelines For Peritoneal Surface Malignancies – Ovary 2020